• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Acceptability of Human Papilloma Virus Self-Sampling for Cervical Cancer Screening in a Cohort of Patients from Romania (Stage 2).罗马尼亚一组患者中用于宫颈癌筛查的人乳头瘤病毒自我采样的可接受性(第2阶段)。
J Clin Med. 2022 Apr 29;11(9):2503. doi: 10.3390/jcm11092503.
2
Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.HPV 自我采样作为一种替代方法在筛查不足人群中进行宫颈癌初筛的可接受性和可行性:一项横断面研究。
Int J Environ Res Public Health. 2020 Aug 27;17(17):6245. doi: 10.3390/ijerph17176245.
3
The Acceptability and Preference of Vaginal Self-sampling for Human Papillomavirus (HPV) Testing among a Multi-ethnic Asian Female Population.多民族亚洲女性人群对人乳头瘤病毒(HPV)检测用阴道自我采样的可接受性和偏好。
Cancer Prev Res (Phila). 2021 Jan;14(1):105-112. doi: 10.1158/1940-6207.CAPR-20-0280. Epub 2020 Sep 11.
4
Women's intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program.在一项有组织的宫颈癌筛查项目中,女性自行采集人乳头瘤病毒检测样本的意愿。
BMC Public Health. 2014 Oct 10;14:1060. doi: 10.1186/1471-2458-14-1060.
5
Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.参与干预措施和建议对宫颈癌筛查未参与者进行随访-考虑到女性自身首选的检测方法-一项瑞典随机对照试验。
PLoS One. 2020 Jul 2;15(7):e0235202. doi: 10.1371/journal.pone.0235202. eCollection 2020.
6
Human Papilloma Virus (HPV) self-sampling: do women accept it?人乳头瘤病毒(HPV)自我采样:女性会接受吗?
J Obstet Gynaecol. 2018 Apr;38(3):402-407. doi: 10.1080/01443615.2017.1379061. Epub 2018 Jan 31.
7
Determinants of women's likelihood of vaginal self-sampling for human papillomavirus to screen for cervical cancer in Taiwan: a cross-sectional study.台湾地区女性进行人乳头瘤病毒阴道自我采样以筛查宫颈癌可能性的决定因素:一项横断面研究。
BMC Womens Health. 2014 Nov 25;14:139. doi: 10.1186/s12905-014-0139-0.
8
Attitudes and factors affecting acceptability of self-administered cervicovaginal sampling for human papillomavirus (HPV) genotyping as an alternative to Pap testing among multiethnic Malaysian women.在马来西亚多民族女性中,影响自我采集宫颈阴道样本进行人乳头瘤病毒(HPV)基因分型以替代巴氏试验的可接受性的态度和因素。
BMJ Open. 2016 Aug 4;6(8):e011022. doi: 10.1136/bmjopen-2015-011022.
9
Muslim immigrant women's views on cervical cancer screening and HPV self-sampling in Ontario, Canada.加拿大安大略省穆斯林移民女性对宫颈癌筛查和人乳头瘤病毒自我采样的看法。
BMC Public Health. 2016 Aug 24;16(1):868. doi: 10.1186/s12889-016-3564-1.
10
Understanding the Acceptability and Uptake of HPV Self-Sampling Amongst Women Under- or Never-Screened for Cervical Cancer in Toronto (Ontario, Canada): An Intervention Study Protocol.了解安大略省多伦多市未经宫颈癌筛查或筛查不足的女性对 HPV 自我采样的可接受性和采用情况:一项干预研究方案。
Int J Environ Res Public Health. 2021 Aug 29;18(17):9114. doi: 10.3390/ijerph18179114.

引用本文的文献

1
A Prospective Study on the Progression, Recurrence, and Regression of Cervical Lesions: Assessing Various Screening Approaches.一项关于宫颈病变进展、复发和消退的前瞻性研究:评估各种筛查方法。
J Clin Med. 2024 Feb 28;13(5):1368. doi: 10.3390/jcm13051368.

本文引用的文献

1
Cost of community-based human papillomavirus self-sampling in Peru: A micro-costing study.秘鲁基于社区的人乳头瘤病毒自我采样成本:一项微观成本核算研究。
Lancet Reg Health Am. 2022 Apr;8. doi: 10.1016/j.lana.2021.100160. Epub 2021 Dec 29.
2
Human Papillomavirus Self-Sampling for Primary Cervical Cancer Screening in Under-Screened Women in Hong Kong during the COVID-19 Pandemic.人乳头瘤病毒自我采样在 COVID-19 大流行期间用于香港筛查不足女性的原发性宫颈癌筛查。
Int J Environ Res Public Health. 2022 Feb 24;19(5):2610. doi: 10.3390/ijerph19052610.
3
Knowledge, attitude and practice of female university students regarding human papillomavirus and self-sampling in KwaZulu-Natal, South Africa: a cross-sectional survey.南非夸祖鲁-纳塔尔省女大学生对人乳头瘤病毒和自我采样的知识、态度和实践:一项横断面调查。
BMC Womens Health. 2022 Mar 4;22(1):58. doi: 10.1186/s12905-022-01634-z.
4
Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study.荷兰常规初级HPV筛查中高危型HPV自我采样与临床医生采样的临床性能:一项观察性研究。
Lancet Reg Health Eur. 2021 Nov 9;11:100235. doi: 10.1016/j.lanepe.2021.100235. eCollection 2021 Dec.
5
Rural-urban differences in HPV testing for cervical cancer screening.宫颈癌筛查中HPV检测的城乡差异。
J Rural Health. 2022 Mar;38(2):409-415. doi: 10.1111/jrh.12615. Epub 2021 Sep 10.
6
Knowledge, utilization and barriers of cervical cancer screening among women attending selected district hospitals in Kigali - Rwanda.卢旺达基加利部分地区医院女性宫颈癌筛查的认知、利用情况及障碍
Can Oncol Nurs J. 2021 Jul 1;31(3):266-274. doi: 10.5737/23688076313266274. eCollection 2021 Summer.
7
Disparities in the change of cervical cancer mortality rate between urban and rural Chiang Mai in the era of universal health care and the Thai national screening program.在全民医保和泰国国家筛查计划时代,清迈城乡宫颈癌死亡率变化的差异。
Int J Equity Health. 2021 Jul 29;20(1):175. doi: 10.1186/s12939-021-01515-1.
8
Self-collected versus clinician-collected cervical samples for the detection of HPV infections by 14-type DNA and 7-type mRNA tests.自我采集与临床医生采集的宫颈样本用于检测 HPV 感染的 14 型 DNA 和 7 型 mRNA 测试。
BMC Infect Dis. 2021 May 31;21(1):504. doi: 10.1186/s12879-021-06189-2.
9
Cervical pap smears and pandemics: The effect of COVID-19 on screening uptake & opportunities to improve.宫颈抹片检查与大流行:COVID-19 对筛查参与度的影响及改善机会。
Womens Health (Lond). 2021 Jan-Dec;17:17455065211017070. doi: 10.1177/17455065211017070.
10
Challenges in the Prevention of Cervical Cancer in Romania.罗马尼亚宫颈癌防治面临的挑战。
Int J Environ Res Public Health. 2021 Feb 10;18(4):1721. doi: 10.3390/ijerph18041721.

罗马尼亚一组患者中用于宫颈癌筛查的人乳头瘤病毒自我采样的可接受性(第2阶段)。

Acceptability of Human Papilloma Virus Self-Sampling for Cervical Cancer Screening in a Cohort of Patients from Romania (Stage 2).

作者信息

Grigore Mihaela, Vasilache Ingrid-Andrada, Cianga Petru, Constantinescu Daniela, Duma Odetta, Matasariu Roxana Daniela, Scripcariu Ioana-Sadiye

机构信息

Department of Obstetrics and Gynecology, 'Grigore T. Popa' University of Medicine and Pharmacy, 700115 Iasi, Romania.

Department of Immunology, 'Grigore T. Popa' University of Medicine and Pharmacy, 700115 Iasi, Romania.

出版信息

J Clin Med. 2022 Apr 29;11(9):2503. doi: 10.3390/jcm11092503.

DOI:10.3390/jcm11092503
PMID:35566630
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9099630/
Abstract

(1) Background: Low patient’s adherence to conventional cervical cancer screening methods determined the need to take into consideration alternative approaches, and vaginal HPV self-sampling is one of them. We aimed to evaluate, using an online survey, the Romanian women’s acceptability of vaginal HPV self-sampling. (2) Methods: A 13-questions online survey was distributed on three Facebook groups, and the results were summarized. (3) Results: Despite of good educational background, 10.8% (n = 60) of the respondents did not know what a Pap smear is, and 33% (n = 183) were not informed about the free national cervical cancer screening program. Multivariate analysis revealed an increased likelihood of vaginal self-sampling acceptance among respondents who did not know about Pap test (OR: 7.80; 95%CI: 1.062−57.431; p = 0.021), national cervical cancer screening program (OR: 1.96; 95%CI: 1.010−3.806; p = 0.02), HPV infection (OR: 7.35; 95%CI: 3.099−17.449; p< 0.001) or HPV test (OR: 1.67; 95%CI: 0.950−2.948; p = 0.03). Moreover, women who did not previously undergo a cervical cancer screening program were more likely to accept the new screening method (OR: 1.62; 95%CI: 0.878−3.015; p = 0.04). (4) Conclusions: Our results showed high acceptability rates of vaginal HPV self-sampling among participants.

摘要

(1)背景:患者对传统宫颈癌筛查方法的依从性较低,因此需要考虑其他替代方法,阴道人乳头瘤病毒(HPV)自我采样就是其中之一。我们旨在通过在线调查评估罗马尼亚女性对阴道HPV自我采样的接受度。(2)方法:在三个脸书群组中开展了一项包含13个问题的在线调查,并对结果进行了总结。(3)结果:尽管受访者教育背景良好,但仍有10.8%(n = 60)的人不知道巴氏涂片检查是什么,33%(n = 183)的人未听说过国家免费宫颈癌筛查项目。多因素分析显示,对巴氏试验不了解的受访者接受阴道自我采样的可能性增加(比值比:7.80;95%置信区间:1.062 - 57.431;p = 0.021),对国家宫颈癌筛查项目不了解的受访者接受阴道自我采样的可能性增加(比值比:1.96;95%置信区间:1.010 - 3.806;p = 0.02),感染HPV的受访者接受阴道自我采样的可能性增加(比值比:7.35;95%置信区间:3.099 - 17.449;p < 0.001),对HPV检测不了解的受访者接受阴道自我采样的可能性增加(比值比:1.67;95%置信区间:0.950 - 2.948;p = 0.03)。此外,之前未参加过宫颈癌筛查项目的女性更有可能接受新的筛查方法(比值比:1.62;95%置信区间:0.878 - 3.015;p = 0.04)。(4)结论:我们的结果显示参与者对阴道HPV自我采样的接受率较高。